Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Agents and mechanisms of toxic myopathy.

Current opinion in neurology - 1 Oct 2009

Kuncl Ralph W

Abstract excerpt

PURPOSE OF REVIEW: Mechanistic-based research has made possible a more pathophysiologic approach to certain drug-induced muscle disorders, especially those caused by the lipid-lowering statin family of drugs, but also myopathies caused by antimicrotubule drugs, mitochondrial toxins, foods, and purported nutriceutical remedies. This is a critical review of those syndromes that are most well founded on evidence of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Diagnosis, Differential
Share to Drug-Induced Ocular Toxicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Lipoproteins and Cardiovascular Health

Share to Microbial Metabolism and Applications

Share to Muscular Diseases

Source

Identifiers

PMID: 19680127
DOI: 10.1097/WCO.0b013e32833045a0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Agents and mechanisms of toxic myopathy.PMID 19680127Read ↗

Clinical characterization and molecular mechanisms of statin myopathy.Semantic proximity Read ↗

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle ComponentsSemantic proximity Read ↗

Iatrogenic myopathies.Semantic proximity Read ↗

Drug-induced myopathies.Semantic proximity Read ↗

Statin-associated myopathy: from genetic predisposition to clinical management.Semantic proximity Read ↗

Statin-associated muscle toxicity : clinical and genomic perspectivesSemantic proximity Read ↗

Approach to clinical and genetic characterization of statin-induced myopathy.Semantic proximity Read ↗

Pathogenesis and treatment of mitochondrial myopathies: recent advances.Semantic proximity Read ↗

Investigating mitochondrial impairment as a mechanism of statin-induced muscle toxicitySemantic proximity Read ↗

Other Myopathies.Semantic proximity Read ↗

Pharmacogenomic insights into treatment and management of statin-induced myopathySemantic proximity Read ↗

Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.